Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray Incorporated announced late Friday it’s entering a 10-year tie-up with the University of Wisconsin School of Medicine and Public Health. The two plan to work on customized cancer treatments with Accuray’s Stellar adaptive radiation therapy platform. Accuray put out the news after the Nasdaq close, a detail that mattered for the already struggling stock.
16 May 2026
Gold Drops on Dollar Gains, Wall Street Sinks as Yields Jump

Gold Drops on Dollar Gains, Wall Street Sinks as Yields Jump

Dollar climbs for fifth day, gold slips, Nasdaq breaks streak The dollar gained for a fifth day on Friday, while gold fell to its lowest in over a week. Higher oil prices, firm U.S. data and surging Treasury yields pushed investors to reconsider how the Federal Reserve could move next. U.S. stocks dropped, and the Nasdaq ended its six-week run of gains.
16 May 2026
TD Securities Filing Throws Spotlight on GCT Semiconductor (GCTS), Raises Flags About 5G Chip Scale-Up and Liquidity

TD Securities Filing Throws Spotlight on GCT Semiconductor (GCTS), Raises Flags About 5G Chip Scale-Up and Liquidity

TD Securities LLC reported a 4.6% stake in GCT Semiconductor Holding, Inc., according to a Schedule 13G/A filed Friday. That’s 3,456,392 shares—all but a sliver linked to warrants, the filing said. The update comes as investors continue to watch if the small-cap chip designer’s 5G pipeline is shifting out of test mode into actual shipments.
1 73 74 75 76 77 890
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY

Pfizer

NYSE: PFE 93 / 100
#2 TACTICAL BUY

AMD

NASDAQ: AMD 91 / 100
#3 STRONG BUY

AerCap

NYSE: AER 90 / 100
#4 BUY ONLY ON PULLBACK

Booking Holdings

NASDAQ: BKNG 88 / 100
#5 BUY ON WEAKNESS

Visa

NYSE: V 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.